Global Drug Discovery Informatics Market Is Expected to Reach USD 4.13 Billion by 2027 : Fior Markets

GlobeNewswire Tuesday, 29 September 2020
Drug Discovery Informatics Market by Solution (Services, Software), Function (Docking, Library & Database Preparation, Molecular Modeling, Sequencing & Target Data Analysis, Others), Application (Drug Discovery, Drug Development), End-User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Others), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027

Newark, NJ, Sept. 29, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the *global drug discovery informatics market* is expected to grow from USD 2 billion in 2019 to USD 4.13 billion by 2027, at a CAGR of 9.5% during the forecast period 2020-2027.

Drug discovery informatics is used to study vast databases of clinical information in order to help researchers in identifying potential drug options for the development of new drugs by using drug discovery informatics services. Some of the key factors that are driving the market growth are increasing R&D expenditure, rising support for research, specifically in the field of rare diseases, the growing use of informatics in drug discovery, expanding growing biotech industry, advancements in software versions for data visualization, data processing, data analysis, & data aggregation, and increasing use of cloud-based services. One of the main developments driving the market growth is the emergence of in silico tools that enable computation with varying workflows that are in line with the pace of modern medicinal chemistry.

With the outbreak of a global pandemic, many have faced salary cuts and job losses. Covid-19 has become a threat to the entire world’s economy and has negatively impacted all kinds of markets. However, covid-19 has come as a boon for the drug discovery informatics market as pharmaceuticals, research institutes, and others are racing to find a cure for the virus. The lack of skilled professionals and the costs involved in the setup of informatics software is expected to hinder the global drug discovery informatics market growth.


Key players operating in the global drug discovery informatics market include Jubilant Life Sciences Limited, Eurofins Scientific, Charles River Laboratories International, Thermo Fisher Scientific, IBM, Schrödinger, Inc., Clarivate Analytics, Evotec AG, Dassault Systèmes, Accenture, Cognizant, Albany Molecular Research, and GVK Biosciences among others. To gain a significant market share in the global drug discovery informatics market, the key players are now focusing on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint ventures, collaborations, and partnerships. Charles River Laboratories and Clarivate Analytics are some of the biggest manufacturers and suppliers of drug discovery informatics in the global market.

· For instance, Jubilant Life Sciences partnered with Orion Corporation in 2017 to provide drug discovery services. These partnerships help the organization achieve commercial success and promote its expertise in the field of drug discovery informatics.
· Evotec teamed up with Takeda Pharmaceutical Company Limited in September 2019 to create five drug discovery programmes with Evotec clinical candidates for further clinical development by Takeda over multiple therapy areas.

*Software dominated the market and held the largest market share of 62.5% in the year 2019*

On the basis of solution, the market has been divided into services and software. Software dominated the market and held the largest market share of 62.5% in the year 2019. The large share of this segment can be attributed to the efficient & quick management of data generated in the drug discovery process by utilizing discovery informatics software solutions.

*Sequencing & target data analysis dominated the market and valued at USD 520 million in the year 2019*

Based on function, the market has been segmented into docking, library & database preparation, molecular modeling, sequencing & target data analysis, and others. Sequencing & target data analysis dominated the market and valued at USD 520 million in the year 2019. The large share of this segment is attributed to the increased use for sequencing analysis techniques for new drugs and improved processing of information from multiple sources & domains.

*Browse full report with TOC at*

*Drug development dominated the market and held the largest market share of 65.1% in the year 2019*

The application segment comprises of drug discovery and drug development. Drug development dominated the market and held the largest market share of 65.1% in the year 2019. The large share of this segment can be mainly attributed to rising investments in R&D for new drug molecules and the increasing need for time & cost optimization for drug development.

*Pharmaceutical companies dominated the market and valued at USD 680.7 million in the year 2019*Based on end-user, the global market has been segmented into biotechnology companies, pharmaceutical companies, contract research organizations, and others. Pharmaceutical companies dominated the market and valued at USD 680.7 million in the year 2019. The growth of this segment is due to pharmaceutical companies currently using drug discovery informatics software intensively for compound screening, pre-clinical R&D, lead identification, & target identification, and are also streamlining their drug discovery processes.

*Regional Segment Analysis of the Drug Discovery Informatics Market*· North America (U.S., Canada, Mexico) 
· Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
· Asia-Pacific (China, Japan India, Rest of APAC)
· South America (Brazil and Rest of South America) 
· Middle East and Africa (UAE, South Africa, Rest of MEA)

On the basis of geography, the global drug discovery informatics market has been classified into North America, Europe, South America, Asia Pacific, and Middle East and Africa. The North America region accounted for the major market share of 52.8% in the year 2019 (followed by Europe) and is anticipated to grow throughout the projected period. The large share of this segment is attributed to key factors such as the existence of well-established CROs and increasing R&D expenditure by biopharmaceutical & pharmaceutical companies. On the other hand, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period 2020-2027. This growth is due to factors like the rapid growth in the biopharmaceutical & pharmaceutical industries and the increasing number of CROs.

*Request for Customization:*

*About the report: *

The global drug discovery informatics market is analyzed on the basis of value (USD Billion). All the segments have been analyzed on a global, regional, and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers an in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

*For Instant Purchase:*

*Customization of the Report:*

The report can be customized as per client requirements. For further queries, you can contact us on [email protected] or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

*About Fior Markets*

Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients’ objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.

*Contact Us*

Avinash D
Head of Business Development
*Phone:* +1-201-465-4211
*Email:* [email protected]

*To Read Top Industries Reports, Visit our Affiliated Website: **

*Related Reports*

Opioid Use Disorder Market -
Point of Care Diagnostics Market -
Tissue Engineered Skin Substitutes Market -
Amoxicillin Market -

You Might Like

Related news from verified sources

Global Drug Discovery Outsourcing Market Is Expected to Reach USD 6.75 Billion by 2027 : Fior Markets

Drug Discovery Outsourcing Market by Product (Small Molecules and Large Molecules), Workflow (Lead Identification and Candidate Optimization, Target...

Global Drug Discovery Services Market (2020 to 2025) - Growth in the Biologics Market Presents Opportunities

Dublin, Sept. 16, 2020 (GLOBE NEWSWIRE) -- The "Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal...

The drug discovery services market is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0%

Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market. ’’. The drug...